Industry Leaders Gather for Annual Great Debates & Updates in Hematologic Malignancies Conference in New York City on April 13-14

Share Article

Over 200 hematologists, oncologists, and other healthcare professionals will participate in a debate-style conference on hematology cancers.

HMP, a leading healthcare content and events company, today announced that Imedex, a wholly owned subsidiary of HMP, will hold the 11th annual Great Debates & Updates in Hematologic Malignancies on April 13-14, 2018 at the Downtown Marriott in New York City. With more than 250 hematology and oncology healthcare professionals in attendance, this debate-style meeting will focus on how the latest clinical insights can be applied within community hematology practices.

The two-day conference will feature didactic and debate-heavy courses where audience participation is encouraged. The scientific program includes sessions on plasma cell disorders, chronic myeloid leukemia, chronic lymphocytic leukemia and “not-so-benign” hematology. On Saturday, attendees will be able to participate in courses on acute leukemias, MPNs, MDS, and lymphomas.

“Our objective is to combine the most recent scientific discoveries with lively debates to create an interactive educational event that drives collective improvement of patient care and outcomes,” said Dan Lowrie, president, Imedex. “I want to thank Drs. Steensma, Leonard, and Orlowski for again helping us put together the dynamic and relevant agenda for this year’s event.”

While the meeting welcomes all healthcare professionals who are involved with or interested in the treatment of patients with hematologic malignancies, up to 12.25 CME credits are available for physicians, nurses and pharmacists.

In addition to the provocative educational program, there will also be 19 companies exhibiting at the meeting, the highest number since the conference began in 2007.

For more information, visit:

About HMP
HMP is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the monthly, award-winning digital platform relied upon by primary care providers; Psych Congress, the largest independent mental health meeting in the U.S.; the ESMO World Congress on Gastrointestinal Cancers; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit

About Imedex®
Imedex® an HMP company, is an industry leader in the creation of independent, accredited medical education for healthcare professionals that improves patient care around the world. With an emphasis in oncology, hematology, and gastroenterology, the company develops high-quality scientific programming that translates the latest research into clinically relevant information. Imedex provides more than 50,000 e-learning experiences annually and since 2001, its live conferences have welcomed more than 100,000 attendees.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kelly McCurdy
+1 610.560.0500 x4304 Ext: 4304
Email >
Follow us on
Visit website